Literature DB >> 20067146

Osteosarcoma of medial cuniform bone.

Daniel Admassi1.   

Abstract

Osteosarcoma is most common primary bone malignancy of childhood and adolescent that is not related to marrow cells. Osteosarcoma usually occurs at the end of long bones commonly around the knee joint. Osteosarcoma of small bones of the foot is very rare. Here I tried to present osteosarcoma of the medial cuneiform bone of the foot in 21 years old male patient.

Entities:  

Mesh:

Year:  2009        PMID: 20067146

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  6 in total

1.  Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells.

Authors:  An-yuan Cheng; Yan Zhang; Hong-jun Mei; Shuo Fang; Peng Ji; Jian Yang; Ling Yu; Wei-chun Guo
Journal:  Tumour Biol       Date:  2015-01-07

Review 2.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Authors:  Jinglei Miao; Song Wu; Zhi Peng; Mousumi Tania; Chaoyue Zhang
Journal:  Tumour Biol       Date:  2013-08

3.  Effect of Period 2 on the proliferation, apoptosis and migration of osteosarcoma cells, and the corresponding mechanisms.

Authors:  Tao Qin; Xiao-Ting Lu; Yong-Gang Li; Yan Liu; Wenjiang Yan; Na Li; Yuan-Yuan Sun
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

4.  MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6.

Authors:  Kegan Zhu; Lei Liu; Junliang Zhang; Yanbo Wang; Hongwei Liang; Gentao Fan; Zhenhuan Jiang; Chen-Yu Zhang; Xi Chen; Guangxin Zhou
Journal:  Protein Cell       Date:  2016-05-26       Impact factor: 14.870

5.  Procaine Inhibits Proliferation and Migration and Promotes Cell Apoptosis in Osteosarcoma Cells by Upregulation of MicroRNA-133b.

Authors:  Boda Ying; Hong Huang; Hongfei Li; Meng Song; Sizhan Wu; Hongliang Ying
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

6.  Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells.

Authors:  Anyuan Cheng; Yan Zhang; Hongjun Mei; Shuo Fang; Peng Ji; Jian Yang; Ling Yu; Weichun Guo
Journal:  Oncol Lett       Date:  2016-03-01       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.